BISPEZIFISCHE ANTIGENBINDENDE MOLEKÜLE

European patent · EP2748202 · In force

Register entry

Publication number
EP2748202
Application number
EP12755967
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 21, 2012
Published
Jul 2, 2014
Granted
Jul 4, 2018
Protection ends at the latest
Aug 20, 2032
Next annual fee due
Aug 31, 2027
IPC classes
C07K 16/30 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 11178371 23.08.2011
EP 12168189 16.05.2012
PCT application
PCT/EP2012/066213 21.08.2012
PCT publication
WO2013/026831 28.02.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Jul 4, 2018

    Granted

    Published in Swissreg on 04.07.2018

Parties

Holder

Roche Glycart AG

Wagistrasse 10, 8952 Schlieren

Inventor

AUER, Johannes

82445 Schwaigen, DE

BRUENKER, Peter

CH-8335 Hittnau

FAUTI, Tanja

CH-8049 Zuerich

NEUMANN, Christiane

CH-8166 Niederweiningen

KLEIN, Christian

CH-8906 Bonstetten

SCHAEFER, Wolfgang

68199 Mannheim, DE

SUSTMANN, Claudio

81373 München, DE

UMANA, Pablo

CH-8832 Wollerau

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.